Excerpt:“…on the outcome of negotiations among different parties, which is full of uncertainty,” said Xinyao (Criss) Wang, HK/China healthcare analyst at SMARTKARMA in a note. The potential deal would add to a surge in strategic investors and buyout firms tapping Hong Kong for take-private…”
NS6 (Web Content – Asia-Pac. ex Japan)via Bloomberg • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
NS6 (Web Content – Asia-Pac. ex Japan)
